Algorae Pharmaceuticals Limited has released a press release.
Appendix 4C - quarterly
Filed with ASX ·
6ix hasn’t read this filing yet.
Algorae Pharmaceuticals Limited on 6ix
Earlier from Algorae Pharmaceuticals
- LCT extends cash runway with receipt from Vertex acquisition
- LCT to benefit from Semma Therapeutics acquisition by Vertex
- Preliminary Final Report and 2019 Financial Statements
- NTCELL Parkinsons trial patient data 2 years after implant
- NTCELL Parkinsons trial patient data at 18 months
Later from Algorae Pharmaceuticals
- Response to ASX Aware Query
- Amended Appendix 4C
- Preliminary Final Report and 2020 Financial Statements
- LCT CEO Dr Ken Taylor signals intention to retire
- LCT exits peptide projects
Follow Algorae Pharmaceuticals into a list and get an email when it puts out news.
Follow Algorae Pharmaceuticals